Preview Mode Links will not work in preview mode

Mar 31, 2021

Featuring slide presentations and related discussion from Drs Rafael Fonseca and Jonathan L Kaufman, including the following topics:

  • Customized induction and maintenance approaches for newly diagnosed MM; select new developments in relapsed/refractory disease — Rafael Fonseca, MD (0:00)
  • Newly approved and promising...


Mar 31, 2021

Featuring perspectives from Drs Rafael Fonseca and Jonathan L Kaufman on the following topics:

  • Customized induction and maintenance approaches for newly diagnosed MM (0:00)
  • Newly approved and promising investigational agents for MM (28:53)

CME information and select publications


Mar 30, 2021

Featuring an interview with Dr Roberto Iacovelli on the following topics:

  • New hormonal therapies for prostate cancer (0:00)
  • Risk of cardiovascular adverse events with new hormonal therapies for prostate cancer (2:45)
  • Metabolic syndrome related to new hormonal therapies for prostate cancer (9:50)
  • Bone fractures with...


Mar 26, 2021

Featuring an interview with Dr Harry Paul Erba, including the following topics:

  • Improvement in overall survival in the VIALE-A trial with azacitidine/venetoclax compared to azacitidine alone for patients with previously untreated acute myeloid leukemia (AML) ineligible for intensive chemotherapy (0:00)
  • Delay in time to...


Mar 26, 2021

Featuring perspectives from Dr Michael J Birrer on the following topics:

  • Anti-PD-1/PD-L1 Checkpoint Inhibitors for Gynecologic Cancers (0:00)
  • HER2-Positive Endometrial Cancer (43:24)
  • Tisotumab Vedotin and Other Novel Agents in Gynecologic Cancers (47:57)

CME information and select publications